Navigation Links
Siemens Receives FDA Approval for the VERSANT 440 Molecular System
Date:2/18/2008

Siemens Offers Next Generation Molecular Viral Load Testing to the U.S.

Market

DEERFIELD, Ill., Feb. 18 /PRNewswire/ -- Siemens Healthcare (http://www.siemens.com/diagnostics) announced today that its VERSANT(TM) 440 Molecular System has been approved for marketing by the U.S. Food and Drug Administration (FDA) for use with the VERSANT HCV RNA 3.0 assay for management of HCV-infected patients undergoing antiviral therapy. The VERSANT 440 Molecular System represents the next generation in automated viral load testing, providing laboratories with greater throughput and less hands-on time, maximizing productivity to meet the evolving needs of the clinical laboratory.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080218/NYM009 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

"We are pleased to offer clinical laboratories leading-edge solutions in molecular diagnostics that support cost-effective and timely screening and treatment of infectious disease," said Jim Reid-Anderson, Chief Executive Officer, Siemens Healthcare Diagnostics Division. "The VERSANT 440 Molecular system provides clinical laboratories and physicians an outstanding tool that enables quantitative monitoring of Hepatitis C and the delivery of personalized treatment that addresses the unique needs of every patient."

The VERSANT 440 Molecular System is a branched DNA (bDNA) system designed for flexible walk-away automation. Its single room technology and consolidated footprint allow the system the flexibility to fit anywhere in the clinical laboratory. The VERSANT 440 System streamlines workflow by integrating bar code data entry, automated reagent processing, signal amplification detec
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Siemens Healthcare Kicks Off New Era of Expanded Access to High-Field MRI with First Install of Affordable MAGNETOM ESSENZA
2. Delray Beach Mayor Commemorates Diagnostic Centers of America (DCA) $2 Million Purchase from Siemens to Become Only Medical Facility in South Florida with Worlds Most Advanced Cardiac Scanner.
3. VIDEO from Medialink and Siemens: Doctors Trade in their Stethoscopes for Microphones
4. ...And the Grand Prize Goes to... Lockport Memorial Hospital, Winner of Siemens National Win an MRI Contest
5. Siemens Receives FDA 510(K) Clearance for Next Generation Radiation Therapy Solution
6. Tri-State Hospital to Gain Greater Efficiency and Responsiveness in Delivering Patient Care with Siemens Open Communications Solutions
7. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
8. The Polls are Open! America Votes to Decide Which Hospital is the Most Deserving of Siemens Newest MRI Technology
9. Siemens Financial Services, Inc. Announces Completion of Credit Facility With Merit Mountainside, LLC
10. Siemens Releases New Version of INVISION to Aid Customers in Streamlining Clinical Workflow and Improving Quality of Care
11. RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , WASHINGTON, Dec. 1 /PRNewswire-USNewswir...e prisoners and 1,538 federal prisoners were HIV p...ce Statistics (BJS) in the Office of Justice Progr...At yearend 2008, an estimated 5,672 inmates in sta...om 5,762 in 2007. In 2007, about 43 per 10,000 pri...
(Date:12/1/2009)...dentify those who would benefit from liver surgery... Dec. 1 (HealthDay News) -- A CT scan of liver tum...help predict overall survival after chemotherapy, ...in) to cytotoxic chemotherapy has been shown to im...tal cancer and to produce better results in patien...
(Date:12/1/2009)... Practitioners of any medical, l...tion are breathing a sigh of relief this week with... The application, released over the holiday weeke...be voice recordings to do so quickly and seamlessl... (PRWEB) December 1, 2009 -- The iPhone...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNewsw...global leader in the development and delivery of c...e medical, scientific and academic markets, will b... Search, our first-to-market cross-platform search...ogy lexicon, based on the American Psychological A...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/ ...tient enrollment in the randomized clinical trial ...t (Combo Stent). ,, A prospective, randomized, ...luation of an ablu M inal sirolimus coat ED b...nts at up to 20 sites in Asia, Australia, Europe a...
Breaking Medicine News(10 mins):Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
...betes appears to be linked with an increased risk ...study from the Norwegian Institute of Public Healt...showed that five percent of women had had serious ... they had diabetes, while diabetes was seen in onl...
...hrough Innovation Gives Greater Numbers of Pharmac...vo TQ System,s Quantitative and Qualitative ...s., Nov. 13 Focused on the,process of helping fir...nd mass spectrometry (MS) solutions at the,America...
... Last week the California Boar...ringent standards that require nurses to submit fi...r license comes up for renewal every two years. R... Costa Mesa, CA (PRWEB) November 1...
... Grants New Indication for Bothersome Vaginal Symp... Nov. 13 PREMARIN(R),(conjugated estrogens) Vagin...and Drug Administration (FDA) for a new indication...th,Pharmaceuticals, a division of Wyeth (NYSE: WY...
...ing small tissue samples from patients with lung c...cedure called histology) is now being utilized to ...ve survival in some patients with non-small cell l... the University of Chicago., Cancer researchers ha...
... tumors of African-American non-small cell lung ca...mber of copies of the epidermal growth factor rece...f than Caucasians according to a study presented a...actors have been shown to predict long-term outcom...
Other Medicine News:Health News:Possible link between diabetes and pelvic girdle syndrome 2Health News:Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008 2Health News:Waters To Unveil Xevo TQ MS Applications for Improved Drug Discovery at AAPS 2008 3Health News:RecordGone.com Helps California Nurses Expunge Criminal Records to Meet More Stringent Licensing Standards 2Health News:RecordGone.com Helps California Nurses Expunge Criminal Records to Meet More Stringent Licensing Standards 3Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 2Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 3Health News:FDA Approves Low-dose Regimen of PREMARIN Vaginal Cream to Treat Moderate to Severe Postmenopausal Dyspareunia - Painful Sexual Intercourse 4Health News:Research demonstrates differing genetic makeup of lung cancer in African-American patients 2
(Date:12/1/2009)... Radiologist reports 90 percent radiation reductio...swire-USNewswire/ -- Dr. James Earls, a radiologis...n Washington, D.C. will present the findings of a ...unt of radiation heart patients received from CT s...,, Dr. Earls will present the study to the annu...
(Date:12/1/2009)... , PLEASANTON, Calif., Dec. 1 ...ercial Affairs at Microchip Biotechnologies, Inc. ...ab systems executive with more than 30 years of ex...t organizations. Mr. Goldstein will direct Microch...t, sales and customer service operations as the co...
(Date:12/1/2009)..., CLEARWATER, Fla., Dec. 1 CCS Med...f medical supplies, today announced that it has re...Court for District of Delaware (the "Court") for i...ting and proposed sale of substantially all of its... 24, 2009, the Court approved bidding procedures f...
Breaking Medicine Technology:Radiation Reduction in Heart CT Scans Reported in Study 2Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President 2CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2Partnership to accelerate Trudeau Institute discoveries to patient care 8711 1Partnership to accelerate Trudeau Institute discoveries to patient care 8711 2APIC Supports Automated Surveillance Technologies in Prevention of Healthcare Associated Infections 47817 1APIC Supports Automated Surveillance Technologies in Prevention of Healthcare Associated Infections 47817 2APIC Supports Automated Surveillance Technologies in Prevention of Healthcare Associated Infections 47817 3Fountain View of Monroe Participates in Illegal Union Busting Campaign 47815 1Fountain View of Monroe Participates in Illegal Union Busting Campaign 47815 2
...ntibody method for HbA1c provides outstanding accu... agreement with the HPLC method(1) , Near-patien...ur results are reliable(2) , National Glycohemog...hod, as recommended by the ADA** , , , Micr...
Advia WorkCell CDX Modular Automation
Blood Coagulation Analyzer CG Series
Cascade M Manual Coagulation Analyzer
Medicine Products: